EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ATP-citrate lyase controls endothelial gluco-lipogenic metabolism and vascular inflammation in sepsis-associated organ injury

Ranran Li iD, Mei Meng, Ying Chen, Tingting Pan, Yinjiaozhi Li, Yunxin Deng, Ruyuan Zhang, Rui Tian, Wen Xu, Xiangtao Zheng, Fangchen Gong, Jie Liu und 7 weitere

Cell Death & Disease · 06.07.2023 · 14 (7)

DOI: 10.1038/s41419-023-05932-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Death & Disease, online erschienen am 06.07.2023. Verfasst von Ranran Li und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P.R. China. ranranli@shsmu.edu.cn. Hauptthemen laut MEDLINE: Lipogenesis, ATP Citrate (pro-S)-Lyase. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis involves endothelial cell (EC) dysfunction, which contributes to multiple organ failure. To improve therapeutic prospects, elucidating molecular mechanisms of vascular dysfunction is of the essence. ATP-citrate lyase (ACLY) directs glucose metabolic fluxes to de novo lipogenesis by generating acetyl-Co-enzyme A (acetyl-CoA), which facilitates transcriptional priming via protein acetylation. It is well illustrated that ACLY participates in promoting cancer metastasis and fatty liver diseases. Its biological functions in ECs during sepsis remain unclear. We found that plasma levels of ACLY were increased in septic patients and were positively correlated with interleukin (IL)-6, soluble E-selectin (sE-selectin), soluble vascular cell adhesion molecule 1 (sVCAM-1), and lactate levels. ACLY inhibition significantly ameliorated lipopolysaccharide challenge-induced EC proinflammatory response in vitro and organ injury in vivo. The metabolomic analysis revealed that ACLY blockade fostered ECs a quiescent status by reducing the levels of glycolytic and lipogenic metabolites. Mechanistically, ACLY promoted forkhead box O1 (FoxO1) and histone H3 acetylation, thereby increasing the transcription of c-Myc (MYC) to facilitate the expression of proinflammatory and gluco-lipogenic genes. Our findings revealed that ACLY promoted EC gluco-lipogenic metabolism and proinflammatory response through acetylation-mediated MYC transcription, suggesting ACLY as the potential therapeutic target for treating sepsis-associated EC dysfunction and organ injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipogenesisATP Citrate (pro-S)-LyaseHumansInflammationAdenosine TriphosphateOxo-Acid-LyasesMultienzyme Complexes

Substanzen

ATP Citrate (pro-S)-LyaseAdenosine Triphosphatecitrate (pro-3S)-lyaseOxo-Acid-LyasesMultienzyme Complexes

Autor:innen und Institutionen

  • Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P.R. China. ranranli@shsmu.edu.cn.
  • Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P.R. China.
  • Department of Emergency, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P.R. China.
  • National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai, P.R. China.
  • Department of Obstetrics and Gynecology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P.R. China.
  • General intensive care unit, Raymond Poincaré Hospital (APHP), Laboratory of Inflammation and Infection U1173, University of Versailles SQY/INSERM 104 bd Raymond Poincaré, 92380, Garches, France.

ORCID-Profile: Ranran Li

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, R., Meng, M., Chen, Y., Pan, T., Li, Y., Deng, Y., Zhang, R., Tian, R., Xu, W., Zheng, X., Gong, F., Liu, J., Tang, H., Ding, X., Tang, Y., Annane, D., Chen, E., Qu, H., & Li, L. (2023). ATP-citrate lyase controls endothelial gluco-lipogenic metabolism and vascular inflammation in sepsis-associated organ injury. Cell Death & Disease, 14(7). https://doi.org/10.1038/s41419-023-05932-8

Vancouver

Li R, Meng M, Chen Y, Pan T, Li Y, Deng Y, et al. ATP-citrate lyase controls endothelial gluco-lipogenic metabolism and vascular inflammation in sepsis-associated organ injury. Cell Death & Disease. 2023;14(7). doi:10.1038/s41419-023-05932-8

BibTeX
@article{Li2023,
  author = {Li, Ranran and Meng, Mei and Chen, Ying and Pan, Tingting and Li, Yinjiaozhi and Deng, Yunxin and Zhang, Ruyuan and Tian, Rui and Xu, Wen and Zheng, Xiangtao and Gong, Fangchen and Liu, Jie and Tang, Haiting and Ding, Xiaowei and Tang, Yaoqing and Annane, Djillali and Chen, Erzhen and Qu, Hongping and Li, Lei},
  title = {ATP-citrate lyase controls endothelial gluco-lipogenic metabolism and vascular inflammation in sepsis-associated organ injury},
  journal = {Cell Death & Disease},
  year = {2023},
  volume = {14},
  number = {7},
  doi = {10.1038/s41419-023-05932-8}
}
Kostenlos starten →